Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07440706

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Led by Kaiser Clinic and Hospital · Updated on 2026-02-27

60

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient safety and quality of life. Traditional capillary glucose monitoring has limited ability to detect rapid glycemic fluctuations. This prospective randomized study aims to evaluate the efficacy and safety of the iCan i3 continuous glucose monitoring (CGM) system compared to conventional capillary glucose monitoring in detecting hypoglycemic events in post-bariatric patients with late dumping syndrome. Participants will be randomized into two groups: one using CGM and one using standard fingerstick monitoring, and followed for 60 days. Clinical outcomes, hypoglycemia frequency, symptom correlation, and quality of life will be assessed.

CONDITIONS

Official Title

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-65 years
  • History of Roux-en-Y gastric bypass surgery at least 12 months prior
  • Clinical diagnosis of late dumping syndrome
  • Stable body weight with less than 5% variation in the last 3 months
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of diabetes mellitus under treatment
  • Use of antidiabetic medications except acarbose
  • Pregnancy or breastfeeding
  • Cognitive impairment affecting study participation
  • Known allergy to continuous glucose monitoring adhesives
  • Conditions increasing risk of hypoglycemia such as prolonged fasting
  • Active or previous cancer
  • Need for imaging procedures during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kaiser Clínica Hospital Dia

São José do Rio Preto, São Paulo, Brazil, 15015-110

Actively Recruiting

Loading map...

Research Team

R

Roberto Luiz Kaiser Junior, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome | DecenTrialz